HUNYVERS SACA (ALHUN.PA) Stock Fundamental Analysis

EPA:ALHUN • FR0014007LQ2

7.3 EUR
-0.08 (-1.08%)
Last: Feb 23, 2026, 07:00 PM
Fundamental Rating

4

Taking everything into account, ALHUN scores 4 out of 10 in our fundamental rating. ALHUN was compared to 56 industry peers in the Specialty Retail industry. ALHUN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALHUN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ALHUN has reported negative net income.
  • In the past year ALHUN had a positive cash flow from operations.
  • ALHUN had positive earnings in 4 of the past 5 years.
  • ALHUN had a positive operating cash flow in 4 of the past 5 years.
ALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M -4M 6M

1.2 Ratios

  • The Return On Assets of ALHUN (-0.85%) is worse than 64.29% of its industry peers.
  • ALHUN's Return On Equity of -2.71% is on the low side compared to the rest of the industry. ALHUN is outperformed by 60.71% of its industry peers.
  • ALHUN has a Return On Invested Capital of 1.38%. This is in the lower half of the industry: ALHUN underperforms 66.07% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALHUN is below the industry average of 9.76%.
Industry RankSector Rank
ROA -0.85%
ROE -2.71%
ROIC 1.38%
ROA(3y)1.9%
ROA(5y)3.61%
ROE(3y)6.17%
ROE(5y)19.19%
ROIC(3y)5.1%
ROIC(5y)7.41%
ALHUN.PA Yearly ROA, ROE, ROICALHUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 40

1.3 Margins

  • The Operating Margin of ALHUN (0.71%) is worse than 66.07% of its industry peers.
  • In the last couple of years the Operating Margin of ALHUN has grown nicely.
  • Looking at the Gross Margin, with a value of 21.04%, ALHUN is doing worse than 76.79% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALHUN has grown nicely.
Industry RankSector Rank
OM 0.71%
PM (TTM) N/A
GM 21.04%
OM growth 3Y-52.03%
OM growth 5Y16.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.64%
GM growth 5Y4.95%
ALHUN.PA Yearly Profit, Operating, Gross MarginsALHUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALHUN is destroying value.
  • Compared to 1 year ago, ALHUN has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALHUN has more shares outstanding
  • The debt/assets ratio for ALHUN has been reduced compared to a year ago.
ALHUN.PA Yearly Shares OutstandingALHUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M
ALHUN.PA Yearly Total Debt VS Total AssetsALHUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • An Altman-Z score of 2.24 indicates that ALHUN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.24, ALHUN is in line with its industry, outperforming 53.57% of the companies in the same industry.
  • The Debt to FCF ratio of ALHUN is 4.56, which is a neutral value as it means it would take ALHUN, 4.56 years of fcf income to pay off all of its debts.
  • ALHUN has a Debt to FCF ratio (4.56) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that ALHUN is somewhat dependend on debt financing.
  • ALHUN has a Debt to Equity ratio (0.62) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 4.56
Altman-Z 2.24
ROIC/WACC0.21
WACC6.43%
ALHUN.PA Yearly LT Debt VS Equity VS FCFALHUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

  • ALHUN has a Current Ratio of 1.58. This is a normal value and indicates that ALHUN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ALHUN (1.58) is better than 73.21% of its industry peers.
  • ALHUN has a Quick Ratio of 1.58. This is a bad value and indicates that ALHUN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALHUN has a Quick ratio (0.48) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.48
ALHUN.PA Yearly Current Assets VS Current LiabilitesALHUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

5

3. Growth

3.1 Past

  • The earnings per share for ALHUN have decreased strongly by -139.58% in the last year.
  • ALHUN shows a decrease in Revenue. In the last year, the revenue decreased by -5.84%.
  • Measured over the past years, ALHUN shows a very strong growth in Revenue. The Revenue has been growing by 25.60% on average per year.
EPS 1Y (TTM)-139.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.22%
Revenue 1Y (TTM)-5.84%
Revenue growth 3Y8.17%
Revenue growth 5Y25.6%
Sales Q2Q%-6.27%

3.2 Future

  • The Earnings Per Share is expected to grow by 120.13% on average over the next years. This is a very strong growth
  • ALHUN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.52% yearly.
EPS Next Y653.33%
EPS Next 2Y229.65%
EPS Next 3Y120.13%
EPS Next 5YN/A
Revenue Next Year11.51%
Revenue Next 2Y9.35%
Revenue Next 3Y8.52%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALHUN.PA Yearly Revenue VS EstimatesALHUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
ALHUN.PA Yearly EPS VS EstimatesALHUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

  • ALHUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 6.27, the valuation of ALHUN can be described as very cheap.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALHUN indicates a rather cheap valuation: ALHUN is cheaper than 94.64% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.75. ALHUN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 6.27
ALHUN.PA Price Earnings VS Forward Price EarningsALHUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • 69.64% of the companies in the same industry are cheaper than ALHUN, based on the Enterprise Value to EBITDA ratio.
  • 69.64% of the companies in the same industry are more expensive than ALHUN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.72
EV/EBITDA 23.31
ALHUN.PA Per share dataALHUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALHUN's earnings are expected to grow with 120.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y229.65%
EPS Next 3Y120.13%

0

5. Dividend

5.1 Amount

  • ALHUN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HUNYVERS SACA

EPA:ALHUN (2/23/2026, 7:00:00 PM)

7.3

-0.08 (-1.08%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners5.62%
Inst Owner ChangeN/A
Ins Owners2.63%
Ins Owner ChangeN/A
Market Cap28.25M
Revenue(TTM)122.72M
Net Income(TTM)-751.60K
Analysts86.67
Price Target11.73 (60.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15%
PT rev (3m)25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)66.18%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.86%
Revenue NY rev (3m)4.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.27
P/S 0.23
P/FCF 5.72
P/OCF 5.29
P/B 1.02
P/tB 2.1
EV/EBITDA 23.31
EPS(TTM)-0.19
EYN/A
EPS(NY)1.16
Fwd EY15.94%
FCF(TTM)1.28
FCFY17.47%
OCF(TTM)1.38
OCFY18.9%
SpS31.71
BVpS7.17
TBVpS3.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.85%
ROE -2.71%
ROCE 1.95%
ROIC 1.38%
ROICexc 1.38%
ROICexgc 2%
OM 0.71%
PM (TTM) N/A
GM 21.04%
FCFM 4.02%
ROA(3y)1.9%
ROA(5y)3.61%
ROE(3y)6.17%
ROE(5y)19.19%
ROIC(3y)5.1%
ROIC(5y)7.41%
ROICexc(3y)6.57%
ROICexc(5y)10.28%
ROICexgc(3y)9.69%
ROICexgc(5y)14.87%
ROCE(3y)7.22%
ROCE(5y)11%
ROICexgc growth 3Y-47.55%
ROICexgc growth 5Y10.21%
ROICexc growth 3Y-49.99%
ROICexc growth 5Y5.05%
OM growth 3Y-52.03%
OM growth 5Y16.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.64%
GM growth 5Y4.95%
F-Score6
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 4.56
Debt/EBITDA 8.1
Cap/Depr 32.36%
Cap/Sales 0.33%
Interest Coverage 250
Cash Conversion 252.1%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 0.48
Altman-Z 2.24
F-Score6
WACC6.43%
ROIC/WACC0.21
Cap/Depr(3y)101.83%
Cap/Depr(5y)104.22%
Cap/Sales(3y)0.69%
Cap/Sales(5y)0.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-139.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40.22%
EPS Next Y653.33%
EPS Next 2Y229.65%
EPS Next 3Y120.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.84%
Revenue growth 3Y8.17%
Revenue growth 5Y25.6%
Sales Q2Q%-6.27%
Revenue Next Year11.51%
Revenue Next 2Y9.35%
Revenue Next 3Y8.52%
Revenue Next 5YN/A
EBIT growth 1Y-73.1%
EBIT growth 3Y-48.11%
EBIT growth 5Y46.02%
EBIT Next Year69.87%
EBIT Next 3Y34.06%
EBIT Next 5YN/A
FCF growth 1Y195.45%
FCF growth 3Y102.19%
FCF growth 5Y67.52%
OCF growth 1Y222.08%
OCF growth 3Y63.97%
OCF growth 5Y58.02%

HUNYVERS SACA / ALHUN.PA FAQ

What is the ChartMill fundamental rating of HUNYVERS SACA (ALHUN.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALHUN.PA.


Can you provide the valuation status for HUNYVERS SACA?

ChartMill assigns a valuation rating of 5 / 10 to HUNYVERS SACA (ALHUN.PA). This can be considered as Fairly Valued.


What is the profitability of ALHUN stock?

HUNYVERS SACA (ALHUN.PA) has a profitability rating of 2 / 10.


What is the financial health of HUNYVERS SACA (ALHUN.PA) stock?

The financial health rating of HUNYVERS SACA (ALHUN.PA) is 4 / 10.